Leading the way in scientific and operational performance
StarBio International bridges the crucial gap between innovator and commercial reality for enduring, successful biotech companies either in the start-up phase or maturing businesses.
Dr. Kevin Moulder and Dr. Beatriz Goyenechea have developed an international network of trusted associates. These high-performing, talented individuals can be introduced to support your projects.
The pathway to excellence
A scientific lens with a strategic commercial discovery pathway for your future success.
Your success is our success. For investors, founders, start-ups, seed or series. A funding, preclinical or clinical development businesses we perform a high-value due diligence program to establish today’s reality and the path to your successful future.
Fast to high-performance biotech start-up
Early seed capital to capitalised early stage innovators need quality built-in from day one to reach commercial reality.
Start-ups require the commercial rigour to navigate the many pitfalls in this often complex world.
One example of fast to high-performance start-up would be Tusk Therapeutics Limited. We led the scientific and operational formation of Tusk Therapeutics Limited in 2015. Over 3 years the company grew and we were responsible for acquiring 28 talented scientists into the business. We discovered and developed 3 clinic ready programs from conception to clinical readiness. In 2018 Tusk Therapeutics Limited was bought by Roche for £600m.
To discover how we are able to reach your commercial objective, start a conversation with us today.
We’re often asked what can be included and whilst this list is not exhaustive, it is an example of the services we can include:
• Due diligence
• Intellectual property validation
• Business and Development planning
• Scientific success planning
• Regulations
• Laboratory operations
• Meeting industry standards
• Patent strategy
• Target selection
• In-vitro models
• In-vivo models
• Translational
• Biomarkers
• Biodistribution/PK/PD
• Compliance SOPs
• Manufacturing/CMC
• Toxicology
• Regulatory submissions
• Clinical trials
Sustaining a maturing biotech company
Having operated at board level we understand and know how to protect your investment.
F-Star, originally an Austrian company, relocated to Cambridge to establish the technology to an industry standard. Along with the acquisition of talent we were also involved operationally to establish a high performance laboratory. We were also instrumental in striking the first commercial international deals, including Merck-Serono and Boehringer Ingelheim elevating the company to a new level.
As you can see we have a proven track record and operational excellence to drive specific outcomes. Can you afford not to talk to us?
We’re often asked what can be included and whilst this list is not exhaustive, it is an example of the services we can include:
• Due diligence
• Intellectual property validation
• Business and Development planning
• Scientific success planning
• Regulations
• Laboratory operations
• Meeting industry standards
• Patent strategy
• Target selection
• In-vitro models
• In-vivo models
• Translational
• Biomarkers
• Biodistribution/PK/PD
• Compliance SOPs
• Manufacturing/CMC
• Toxicology
• Regulatory submissions
• Clinical trials
